- Home
- GH vs HBM Comparison
GH vs HBM Comparison
Compare GH & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- HBM
- Stock Information
- Founded
- GH 2011
- HBM 1927
- Country
- GH United States
- HBM Canada
- Employees
- GH N/A
- HBM N/A
- Industry
- GH Medical Specialities
- HBM Metal Mining
- Sector
- GH Health Care
- HBM Basic Materials
- Exchange
- GH Nasdaq
- HBM Nasdaq
- Market Cap
- GH 4.3B
- HBM 3.5B
- IPO Year
- GH 2018
- HBM N/A
- Fundamental
- Price
- GH $31.83
- HBM $8.24
- Analyst Decision
- GH Strong Buy
- HBM Buy
- Analyst Count
- GH 14
- HBM 3
- Target Price
- GH $39.93
- HBM $11.17
- AVG Volume (30 Days)
- GH 1.6M
- HBM 3.9M
- Earning Date
- GH 11-06-2024
- HBM 11-13-2024
- Dividend Yield
- GH N/A
- HBM 0.17%
- EPS Growth
- GH N/A
- HBM 267.48
- EPS
- GH N/A
- HBM 0.23
- Revenue
- GH $692,256,000.00
- HBM $2,038,471,000.00
- Revenue This Year
- GH $32.23
- HBM $22.66
- Revenue Next Year
- GH $16.90
- HBM $12.01
- P/E Ratio
- GH N/A
- HBM $37.62
- Revenue Growth
- GH 29.20
- HBM 44.67
- 52 Week Low
- GH $15.81
- HBM $4.94
- 52 Week High
- GH $38.53
- HBM $10.49
- Technical
- Relative Strength Index (RSI)
- GH 45.64
- HBM 41.58
- Support Level
- GH $34.20
- HBM $7.82
- Resistance Level
- GH $36.24
- HBM $9.78
- Average True Range (ATR)
- GH 1.70
- HBM 0.34
- MACD
- GH -0.92
- HBM -0.12
- Stochastic Oscillator
- GH 15.98
- HBM 21.43
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About HBM Hudbay Minerals Inc. (Canada)
Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The major mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, the next biggest source of revenue, to industrial customers across North America.